Clinical Trial Update: Galectin 3 Dosage in Diagnosis of Nodular and Multinodular Goiter [NA]

View source ↗

Summary

A completed clinical trial evaluating Galectin-3 dosage as a diagnostic biomarker for nodular and multinodular goiter.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multinodular Goiter
• Nodular Goiter

Snippet

Sponsor: University Hospital, Rouen | Conditions: Goiter, Nodular | NA | Status: COMPLETED